NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
640.00
+24.00 (3.90%)
At close: Dec 5, 2025
-45.02%
Market Cap 63.28B
Revenue (ttm) 94.29M
Net Income (ttm) -29.66B
Shares Out 98.87M
EPS (ttm) -92.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,197,820
Average Volume 2,267,774
Open 606.00
Previous Close 616.00
Day's Range 603.00 - 645.00
52-Week Range 540.00 - 1,881.00
Beta 0.51
RSI 55.61
Earnings Date Nov 14, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 52
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.